Gerry McDougall, Chairman
PricewaterhouseCoopers LLP, Senior Partner
Mr. McDougall is Senior Partner at PricewaterhouseCoopers Health Sciences Practice, where he provides services to academic medical centers, bioscience companies, pharmaceutical companies, research universities, colleges, health systems, and other research organizations. His practice provides a broad range of research business and compliance services, including strategic and business planning, financial analysis, research compliance, clinical research operations improvement, and information systems implementation services. In addition, his practice provides support services to the entire research continuum, from grant-funded basic science research, to translational research and clinical trials, including a dedicated group focusing on Clinical Research Consulting services and Global oncology.
Walter M. Capone
GeneCentric Therapeutics, Chief Business Officer
Mr. Capone is a dynamic, accomplished, results-driven, global biotech/pharmaceutical leader with a twenty-year track record of accelerating breakthrough science, drug development and commercialization across the immunology, oncology and infectious disease therapeutic areas. In his senior executive roles in organizations ranging from seed-funded start-ups to leading, global biotech and pharma companies, Mr. Capone consistently established and led high performing teams to drive innovative product development, deliver entity-wide strategic and operational effectiveness, and achieve transformative corporate and business development results.
LOOPBACK Analytics, Chief Executive Officer
Neil Smiley is the founder and CEO of Loopback Analytics. Smiley started Loopback Analytics in 2009, after serving for 12 years as the founder and CEO of Phytel, a provider-led population health improvement company acquired by IBM Watson. Smiley started his professional career in management consulting with Accenture and later as a partner with EY, working with Fortune 1000 clients in the manufacturing, high tech, oil and gas, and transportation industries. Smiley serves as President of the Charles H. Hood Foundation, supporting child health research with leading institutions across New England and the Board of the Dartmouth Hood Museum of Art. Additionally, Smiley and his wife Judy are Auction Chairs for the Carson Leslie Foundation for pediatric cancer research. In 2013, Smiley was one of four finalists nominated for the Tech Titans Award for Emerging Technology Innovation in Dallas, and selected as one of the top 25 most influential persons in health care by the Dallas Business Journal. He serves as an active investor and mentor with Health Wildcatters, a health technology accelerator based in Dallas, working with emerging health care startups. Smiley’s passion is to build the kind of company where every employee feels connected to the mission of transforming the country’s health care system to benefit patients and providers. Smiley holds a bachelor’s degree in computer science from Dartmouth College.
Covera Ventures, Managing Director
Steve Coffey is a managing director of Covera Ventures and has more than 20 years of investment experience with companies at all stages of development. Steve leads the Firm’s investments in Alert Logic, CoreTrace, Hubspan, Innography, and Zumobi. Steve was a director or actively involved in such companies as Airspan (NASDAQ: AIRN), iTKO (acquired by CA), Metreos (acquired by Cisco), SiGe (acquired by Skyworks), SNAPin (acquired by Nuance), and Softricity (acquired by Microsoft).
Steve was previously president and managing director of Hunt Ventures and established the Austin office in 1999. Prior to Hunt Ventures, he was vice president of Hunt Financial Corporation, where he evaluated and managed investments in public equities, private equity and venture capital partnerships, and direct investments in both early stage technology companies and buyouts.
Earlier in his career, he worked as an associate at Davis Venture Partners, a private venture capital firm where he worked with both early and later-stage portfolio companies. He previously worked at EDS Corporation and Arthur Andersen, LLP. Steve has a BS from Oklahoma State University and an MBA with honors from The University of Texas.
R. Ripley Martin
Mr. Martin is responsible for leading Philips Ventures, Philips’ corporate venture capital, accelerator and external innovation efforts. He leads a global team of investment and innovation professionals who run a dedicated digital health investment fund and support business-sponsored collaboration investments across themes of radiology & precision medicine, patient telemetry, and ambulatory care.
Prior to Philips, he spent six years with the Boston Consulting Group (BCG) where he was a Principal in the firm’s Healthcare, Industrial Goods and Strategy practices.
Mr. Martin earned his MBA with high distinction from the Ross School of Business at the University of Michigan, and his BA in Economics from Colby College.
He lives in the greater Boston area with his wife and two children.
The Beck Group, Co-Founder Board Director
Project Executive AT&T North TX, Directs $80M Construction Portfolio, Deacon Board Chairman, Covenant School Board – 5 years, University of Nebraska (Bachelor of Science Construction, College School of Engineering)
Co-Founder: Carson Leslie Foundation (CLF)
Chief Mission Officer (Ex. Officio)
Successfully secured/leveraged/directed millions of dollars into childhood cancer/brain cancer research.
Annette has served on the $6B Cancer Prevention and Research Institute of Texas (CPRIT) Advisory Council for Childhood Cancers (ACCC) since 2010. She worked closely with CPRIT’s 1st Chief Scientific Officer, Nobel Laureate, Dr. Alfred Gilman to secure “Carson Leslie Research Grants for Pediatric Brain Cancers”, a $3.2M CPRIT/CLF collaboration. Recognized as leading influencer for CPRIT to make childhood cancer research an institutional priority increasing their investments from barely 3 percent to a whopping 12 percent invested into childhood cancer research; proportionately three times more than the national rate.
As a leading TX childhood cancer Foundation, Leslie fully embraces the differentiated value working with the CPRIT, the 2nd largest funder of cancer research outside the Federal government. With CLF #cureMEdullo focus on childhood brain cancer research, in partnership with CPRIT, we launched Reserchers RoundUp and gathered Texas’ brightest childhood brain cancer investigators facilitating innovative discussions about the problem of childhood brain cancer, the deadliest disease of our nation’s children. New collaborations were initiated and a TX Childhood Brain Cancer Coalition is being formalized.
After reading Cason’s book Carry Me in 2010, Congressman Michael McCaul, Founder of the Congressional Childhood Cancer Caucus (CCCC), invited Annette to speak at the inaugural CCC in his Washington, DC in he and Mrs. Linda’s McCaul’s private home. Since that gathering, under the relentless leadership of Congressman Michael McCaul, members of the Senate and the unyielding childhood cancer community, together we have built an Unstoppable, Bipartisan, Global, Childhood, Cancer, Movement. Together we have passed 4 laws benefiting the overall state of childhood cancer.
Annette Leslie founded and is Chairman of the Golden Toast (GT) in Washington, DC. The Golden Toast is an annual celebration of the accomplishments of the CCCC, the Senate, and the unyielding childhood cancer community for successfully building a SOAPBOX in the most powerful Nation in the world and placing upon that SOAPBOX, the smallest and most innocent cancer patients among us.
CLF built CARSON’S CORNER (CC), a comprehensive teen cancer patient program at Children’s Health-Dallas. The program attracted a valued partnership with the Jordan Spieth Family Foundation which has allowed CC to expand to all the major institutions in Texas who care for teen cancer patients.